Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
C3.ai | AI | Nov 15, 2024 | 25.99 | -1.48 |
C3is | CISS | Nov 15, 2024 | 1.11 | +1.83 |
C4 Therapeutics | CCCC | Nov 15, 2024 | 4.31 | -8.69 |
Cabaletta Bio | CABA | Nov 15, 2024 | 3.03 | -19.84 |
Cabana Target Drawdown 10 ETF | TDSC | Nov 15, 2024 | 25.33 | -0.72 |
Cabana Target Drawdown 7 ETF | TDSB | Nov 15, 2024 | 22.44 | -0.38 |
Cable One | CABO | Nov 15, 2024 | 397.64 | -2.47 |
Cabot | CBT | Nov 15, 2024 | 108.81 | -0.34 |
CACI International A | CACI | Nov 15, 2024 | 470.79 | -4.18 |
Cactus A | WHD | Nov 15, 2024 | 64.36 | -1.89 |
Cactus Acquisition 1 A | CCTS | Nov 15, 2024 | 11.65 | 0.00 |
Cadeler ADR | CDLR | Nov 15, 2024 | 24.13 | +1.17 |
Cadence Bank | CADE | Nov 15, 2024 | 37.70 | -0.84 |
Cadence Bank A | CADE-A | Nov 15, 2024 | 21.01 | -0.43 |
Cadence Design Systems | CDNS | Nov 15, 2024 | 289.71 | -4.40 |
Cadiz | CDZI | Nov 15, 2024 | 3.32 | +2.47 |
Cadiz Pref ADR | CDZIP | Nov 15, 2024 | 16.15 | +0.44 |
Cadre | CDRE | Nov 15, 2024 | 32.52 | -2.93 |
Cadrenal Therapeutics | CVKD | Nov 15, 2024 | 15.66 | -5.49 |
Cae | CAE | Nov 15, 2024 | 21.75 | -1.09 |
Caesars Entertainment | CZR | Nov 15, 2024 | 37.04 | -5.00 |
Caesarstone | CSTE | Nov 15, 2024 | 4.08 | +2.26 |
Cal-Maine Foods | CALM | Nov 15, 2024 | 90.43 | -0.01 |
Calamos Convertible High Fund | CHY | Nov 15, 2024 | 11.95 | -0.91 |
Calamos Convertible Opportunities And Income Fund | CHI | Nov 15, 2024 | 11.69 | -0.58 |
Calamos Dynamic Convertible & Income Fund | CCD | Nov 15, 2024 | 23.88 | -0.54 |
Calamos Global Dynamic Fund | CHW | Nov 15, 2024 | 6.85 | -1.58 |
Calamos Global Total Return Fund | CGO | Nov 15, 2024 | 11.66 | -0.72 |
Calamos Longshort Equity & Dynamic Income Trust | CPZ | Nov 15, 2024 | 15.32 | -1.13 |
Calamos Strategic Total Return Fund - Closed End Fund | CSQ | Nov 15, 2024 | 17.64 | -1.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.